Clinical Performance of Nobel N1 System

NCT ID: NCT07280260

Last Updated: 2025-12-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-12-15

Study Completion Date

2028-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aims to evaluate the survival and stability of the Nobel N1 dental implant and its accompanying crown over a one-year period when the crown is placed either 6 or 12 weeks after implant placement. The Nobel N1 implant is an FDA-approved, newly designed implant featuring an innovative surgical placement protocol intended to minimize bone trauma, promote faster integration, and potentially allow for the placement of final crowns earlier-at 6 weeks instead of the traditional 4 to 5 months. This study will enroll adult participants who are missing a single tooth in the back of the mouth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tooth Loss Dental Implant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study is a two-arm, randomized prospective clinical trial. The randomization of the patients will be done after implant has been placed and if sufficient torque was obtained as outlined previously. At this point, using a computer generated table of random numbers, patients will be randomized into early loading and delayed loading group. Since it is not possible to predict ahead of time what the final torque will be at implant placement, a third group will comprise patients that receive implants that have lower torque that cannot be randomized. These patients will follow traditional one stage or two stage protocol for implant placement and delayed protocol. Irrespective of randomization and torque status and implant placement, all patients will be followed up as part of the study and analyzed based on the group to which they belong.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early loading

Delivery of the final crowns 6 weeks after the implant placement.

Group Type ACTIVE_COMPARATOR

Nobel N1 implant

Intervention Type DEVICE

A Nobel N1 implant will be placed and restored with a On 1 base

Delayed loading

Delivery of the final crowns 12 weeks after the implant placement.

Group Type OTHER

Nobel N1 implant

Intervention Type DEVICE

A Nobel N1 implant will be placed and restored with a On 1 base

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nobel N1 implant

A Nobel N1 implant will be placed and restored with a On 1 base

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females, age 18 or older

* Can provide an Informed Consent in English.
* Absence of a single posterior tooth in mandible or maxilla with presence of natural neighboring teeth (except for second molar which only requires presence of first molar)
* Presence of antagonist teeth
* Possibility and will for an immediate restoration.
* Systemic health recorded as an American Society of Anesthesiologists (ASA) I or II

Exclusion Criteria

* · Unavailability to attend the follow-up visits.

* A systemic contraindication for oral surgical procedures; ASA III or IV.
* Pregnancy or nursing on screening or before the surgical procedure.
* Diseases that could alter healing or bone metabolism (uncontrolled diabetes, diagnostic osteoporosis, etc.),
* Taking medications that are altering healing or bone metabolism (bisphosphonates, long-time corticosteroids intake, RANK inhibitors, etc.)
* Alcohol or drug abuse.
* Current heavy smoking behavior (≥10 cigarettes/day).
* Radiation therapy to the head or neck region.
* Pathology in the implant planned sites that prevent implant placement.
* Current diagnosis of Diabetes, which is uncontrolled (\>7 HbA1C).
* Need for sinus lift or vertical bone augmentation
* Previously failed implant site
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Envista (Nobel Biocare)

UNKNOWN

Sponsor Role collaborator

Louisiana State University Health Sciences Center in New Orleans

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

LSU School of Dentistry

New Orleans, Louisiana, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amir Nejat

Role: CONTACT

504-981-8283

Jeanne St Germain

Role: CONTACT

504-941-8276

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amir Nejat

Role: primary

504-981-8283

Jeanne St Germain

Role: backup

504-941-8276

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

8328

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Wear Characteristics of Denture Teeth
NCT01188226 TERMINATED NA